Orbiepharm

About Orbiepharm

Orbiepharm, established in 2010, is a pioneering company in China dedicated to the development, production, and sale of pet medicines specifically for veterinary hospitals. The company operates in the veterinary pharmaceutical market, focusing on providing innovative health solutions for small animals. Orbiepharm serves veterinary professionals and pet owners by offering a range of products that include advanced medications and health supplements. The business model revolves around research and development, manufacturing, and direct sales to veterinary hospitals, ensuring a steady revenue stream from product sales and partnerships. The company has garnered recognition for its contributions to veterinary medicine, including awards and sponsorships at industry forums and congresses. Orbiepharm's commitment to advancing veterinary care is evident through its collaborations with top industry cardiologists and participation in significant veterinary events. The company's market presence is bolstered by its national veterinary drug approval and its reputation for quality and innovation in pet healthcare.